Inici › Carcinoma de cèl·lules escamoses de cap i coll › Ohio › Cincinnati
Assaigs clínics de Carcinoma de cèl·lules escamoses de cap i coll a Cincinnati, OH
14 estudis de Carcinoma de cèl·lules escamoses de cap i coll busquen participants en centres de Cincinnati i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
ReclutantFase 2/3
- Site#0117, Cincinnati
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
ReclutantFase 3
- University of Cincinnati, Cincinnati
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
ReclutantFase 3
- University of Cincinnati, Cincinnati
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
ReclutantFase 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · a 15 mi
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
ReclutantFase 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- i 4 més
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
ReclutantEstudi observacional
- University of Cincinnati, Cincinnati
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ReclutantFase 2
- St. Elizabeth Healthcare, Edgewood · a 8 mi
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
ReclutantFase 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · a 15 mi
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
ReclutantFase 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · a 15 mi
Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma
ReclutantFase 1/2
- University of Cincinnati Medical Center, Cincinnati
Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma
ReclutantFase 2
- University of Cincinnati Medical Center, Cincinnati
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
ReclutantFase 1/2
- Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center, Cincinnati
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
ReclutantFase 1/2
- Research Site 113, Cincinnati
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
ReclutantFase 1/2
- The Christ Hospital, Cincinnati
Assaigs de Carcinoma de cèl·lules escamoses de cap i coll en altres ciutats
- Houston, TX47 estudis
- Los Angeles, CA42 estudis
- Boston, MA40 estudis
- Nashville, TN39 estudis
- New York City, NY39 estudis
- St. Louis, MO28 estudis
- Arlington, VA26 estudis
- Philadelphia, PA26 estudis
- Chicago, IL26 estudis
- Atlanta, GA24 estudis
- Pittsburgh, PA22 estudis
- New Haven, CT22 estudis
Altres estudis a Cincinnati
- Càncer de pulmó de cèl·lules no petites35 estudis
- Càncer (tots els tipus)27 estudis
- Càncer de mama25 estudis
- Insuficiència cardíaca24 estudis
- Càncer colorrectal21 estudis
- Leucèmia mieloide aguda20 estudis
- Càncer metastàtic20 estudis
- Càncer d'ovari19 estudis
- Càncer de pulmó19 estudis
- Obesitat19 estudis
- Càncer de pròstata18 estudis
- Mieloma múltiple17 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.